Skip to main content
Premium Trial:

Request an Annual Quote

Link Technologies Inks Japanese Distribution Deal

NEW YORK (GenomeWeb News) – Following its first distribution deal for Asia, Link Technologies today announced another deal covering that region, this time with Japanese firm GeneDesign

Under the terms of the agreement, GeneDesign will represent Link throughout Japan. The agreement comes about a month after Link forged a distribution agreement with Zirench Technology covering China.

"By working with GeneDesign, we will be able to provide local access to our high quality products and offer our expert support services to customers throughout Japan," Link CEO John Bremner said in a statement. "This level of accessibility is something we are very keen to continue to develop within Asia and worldwide, and forms part of our ongoing strategic plans for development and growth."

Financial and other terms were not disclosed.

Link is based in Bellshill, Scotland and supplies specialty reagents for oligonucleotide synthesis and modification. GeneDesign is a contract manufacturing organization headquartered in Osaka, Japan. It also provides contract research organization services focused on oligonucleotide chemistry.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.